FormFactor Sinks 12% Despite Record Quarter as Factory Nears “Capacity Limits”
FormFactor (FORM) fell 12% despite record Q3 revenue of $280.5M, with flat Q4 guidance due to factory capacity limits. CEO Mike Slessor noted new factory ramp-up. Analysts expect $1B+ revenue this year. Teradyne (TER) also guided flat, while Onto Innovation (ONTO) reports next. FORM's forward P/E is 27x.
How this was made
The 30-second read
Why it matters
The article frames the selloff as a guidance-driven pause: flat revenue expectations and a gross margin decline as existing manufacturing nears capacity, with the new Farmers Branch facility shipping its first unit and targeting substantial annual capacity by end of next year.
Market read
Traders get a same-day catalyst (guidance and margin outlook) plus near-term sector read-through points (peer guidance and an upcoming advanced-packaging report).
What to watch
Gross margin could be influenced by mix and ramp efficiency, not just capacity limits; investors may be over-weighting the guide’s gross margin giveback without seeing cost absorption trends.
Background
FormFactor reported record Q3 revenue and provided an outlook that is only marginally above the prior quarter, while management said productivity gains are moderating as it approaches capacity limits and a new factory is coming online.
Ticker impact
FormFactor shares fell 12% after record Q3 revenue, but its next-quarter outlook implies flat revenue and a lower gross margin as factory capacity nears limits.
Likely continued pressure as the market prices in flat revenue and gross margin giveback until the new Farmers Branch factory ramps.
The article ties the stock’s same-day drop to guidance that is only slightly above the prior quarter and explicitly flags gross margin decline as capacity limits approach.
Teradyne guided flat revenue for its fourth quarter, which the article uses to frame how much of FormFactor’s pause may be industry-wide versus capacity-specific.
Limited upside impulse; likely neutral-to-cautious trading if investors treat it as confirmation of sector softness.
The article does not claim Teradyne has a capacity squeeze, but its flat guide is used as a comparative datapoint for the same demand pause.
Onto Innovation is highlighted as the next read on advanced packaging, with an early-November report expected to test whether FormFactor’s bottleneck is real.
Potential volatility around the early-November report depending on whether backlog and revenue guide confirm strength or show a slowdown.
The article provides Onto’s backlog and guide range context, but the key catalyst is the upcoming report rather than a disclosed result in this piece.
Market effects
Signals a potential near-term digestion period in advanced packaging/test supply chains, with capacity ramp timing and gross margin sensitivity in focus.
Primarily US-listed semiconductor equipment and advanced packaging sentiment; no direct regional macro linkage described.
Read-through is relevant to global advanced packaging demand expectations, but the article is centered on company-specific capacity and guidance.
Counterpoint
Demand is described as not the constraint, so the margin dip may be temporary and the new Farmers Branch ramp could re-accelerate results sooner than the market assumes.
Key entities
- companyFormFactor
NASDAQ-listed semiconductor test equipment maker; shares dropped 12% on guidance implying flat revenue and lower gross margin near capacity limits.
- companyTeradyne
NASDAQ-listed test equipment peer; guided flat revenue, used as a read-through for whether the pause is industry-wide.
- companyOnto Innovation
NYSE-listed advanced packaging peer; upcoming early-November report is positioned as the next check on the bottleneck thesis.
